Google Scholar | Citations: 16429| h-index: 32 | i10-index: 482
Impact on the reduction of glycated hemoglobin with increased access to medications for the treatment of type 2 diabetes
PDF (Portuguese (Brazil))

Keywords

Diabetes Mellitus
Glycemic control
Glycated hemoglobin

How to Cite

Impact on the reduction of glycated hemoglobin with increased access to medications for the treatment of type 2 diabetes. (2021). Electronic Journal Collection Health, 13(10), e8935. https://doi.org/10.25248/reas.e8935.2021

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: Evaluate glycemic control in type 2 diabetics followed at the endocrinology outpatient clinic of a tertiary hospital in the Northeast in the use of oral antidiabetic agents and insulin dispensed by the specialized drugstore. Methods: Observational and transversal study. The variables considered were the level of glycated hemoglobin (HbA1c), sex, age, origin, diagnosis time, treatment time, the frequency of visits per year, class of medications used and presence of comorbidities. The data were analyzed in the R software version 3.5.1. The sample was characterized by absolute and percentage frequencies, mean and standard deviation, and used the Anderson-Darling test, Levene, Student t, Student t paired, McNemar, Pearson's chi-square, and finally the ratio odds was calculated. Results: A total of 130 patients were analyzed, 95 were eligible to participate in the study, 62.1% were female. The initial frequency of adequate glycemic control was 15% and after follow-up was increased to 48%. The initial mean HbA1c was 8.6 ± 1.60 and after 7.4 ± 1.65. Conclusion: Patients analyzed had a better control comparing the onset with the present moment, evidenced by both the increase in the number of patients with HbA1c ≤ 7 and the reduction in the mean of glycated hemoglobin.

PDF (Portuguese (Brazil))